Absorption of rectally administered phenytoin: A pilot study

Annals of Pharmacotherapy

Volumn 33, Issue 7-8, 1999, Pages 781-786

  Chang, Sandra W ^a,b   Da Silva, Jack H ^c   Kuhl, David R ^c  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c NONE

Author keywords

Absorption; Phenytoin; Rectal administration

Indexed keywords

PHENYTOIN;

ADULT; ARTICLE; ATAXIA; CLINICAL TRIAL; CONVULSION; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HUMAN EXPERIMENT; HYPOTENSION; INJECTION PAIN; INTRAVENOUS DRUG ADMINISTRATION; LETHARGY; MALE; NAUSEA; NORMAL HUMAN; NYSTAGMUS; PRIORITY JOURNAL; RASH; RECTAL DRUG ADMINISTRATION; TACHYCARDIA; VERTIGO; VISUAL IMPAIRMENT;

EID: 0032782997     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.18335     Document Type: Article

References (19)

1. McEvoy GK, ed. AHFS drug information 98. Bethesda, MD: American Society of Health-System Pharmacists, 1998:1752-5.
2. Tozer TN, Winter ME. Phenytoin. In: Evans WE, Schentag JJ, Jusko WJ, eds. Applied pharmacokinetics: principles of therapeutic drug monitoring. Vancouver, WA: Applied Therapeutics, Inc., 1992:25-1-25-44.
3. Kostenbauder HB, Rapp RP, McGovren JP, Foster TS, Perrier DG, Blacker HM, et al. Bioavailability and single-dose pharmacokinetics of intramuscular phenytoin. Clin Pharmacol Ther 1975;18:449-56.
4. Warren DE. Practical use of rectal medications in palliative care. J Pain Symptom Manage 1996;11:378-87.
5. Graves NM, Kriel RL. Rectal administration of antiepileptic drugs in children. Pediatr Neurol 1987;3:321-6.
6. Package insert. TDx/TDxFLx phenytoin assay list no. 9507. Abbott Park, IL: Abbott Laboratories Diagnostics Division, 1996:1-5.
7. Bauer LA. Individualization of drug therapy: clinical pharmacokinetics and pharmacodynamics. In: DiPiro JT, Talbert RL, Hayes PE, Yee GC, Matzke GR, Posey LM, eds. Pharmacotherapy: a pathophysiologic approach. 2nd ed. Norwalk, CT: Appleton & Lange, 1993:15-31.
8. Jusko WJ, Koup JR, Alván G. Nonlinear assessment of phenytoin bioavailability. J Pharmacokinet Biopharm 1976;4:327-36.
9. van Hoogdalem EJ, de Boer AG, Breimer DD. Pharmacokinetics of rectal drug administration, part I. General considerations and clinical applications of centrally acting drugs. Clin Pharmacokinet 1991;21:11-26.
10. van Hoogdalem EJ, de Boer AG, Breimer DD. Pharmacokinetics of rectal drug administration, part II. Clinical applications of peripherally acting drugs, and conclusions. Clin Pharmacokinet 1991;21:110-28.
11. Pienaar EW, Boneschans B, Koeleman HA. Rectal absorption of phenytoin in rabbits from polyethylene glycol suppositories. Drug Dev Ind Pharm 1991;17:1397-404.
12. Fuerst RH, Graves NM, Kriel RL, Olson R. Absorption and safety of rectally administered phenytoin. Eur J Drug Metab Pharmacokinet 1988; 13:257-60.
13. Moolenar F, Jelsma RBH, Visser J, Meijer DKF. Manipulation of rectal absorption rate of phenytoin in man. Pharm Weekblad Sci Ed 1981;3: 175-80.
14. Yazan Y, Erol K. Comparison of the bioavailability of oral and rectal forms of diphenylhydantoin sodium. Drug Dev Ind Pharm 1990;16: 1849-56.
15. Robinson DH, Narducci WA, Ueda CT. Drug delivery and administration. In: DiPiro JT, Talbert RL, Hayes PE, Yee GC, Matzke GR, Posey LM, eds. Pharmacotherapy: a pathophysiologic approach. 2nd ed. Norwalk, CT: Appleton & Lange, 1993:32-55.
16. Clark LA, Millam DA, Poyss AS, Starsiak D. Photoguide to drug administration. Springhouse, PA: Springhouse Corporation, 1992:29,71.
17. Browne TR, Davoudi H, Donn KH, Dougherty CL, Dukes GE, Evans B, et al. Bioavailability of ACC-9653 (phenytoin prodrug). Epilepsia 1989; 30(suppl 2):S27-32.
18. Leppik IE, Boucher BA, Wilder BJ, Murthy VS, Watridge C, Graves NM, et al. Pharmacokinetics and safety of a phenytoin prodrug given IV or IM in patients. Neurology 1990;40:456-60.
19. Reynolds JEF, ed. Martindale: the extra pharmacopoeia. London: Royal Pharmaceutical Society, 1996:380-6.